PetLife Pharmaceuticals, Inc. announce the additions of Dr. Joel Beth Mitchel-Navratik, Vice President of Veterinary Affairs, and Dr. Vivek Ramana, Chief Medical Officer, to the management team. Dr. Mitchel-Navratik will be responsible for liaison with the professional veterinary community and will lead the clinical portion of company upcoming FDA trials. Since 2001, Dr. Joel Beth Mitchell Navratik has served as the Corporate Medical Director for Pet Medical Centers, LLC. in South Florida. Dr. Ramana has extensive experience in bringing drugs through the FDA approval process and has over four years experience working with Escozine in the laboratory and clinical setting. Dr. Ramana will be responsible for building and maintaining company portfolio of scientific studies supporting the safety and efficacy of Escozine for Pets. PetLife will have a Pre-INAD meeting with CVM and subsequently conduct the require studies per FDA guidance. He will oversee the safety, toxicology, and clinical studies portions of company upcoming FDA trial and be the company direct liaison with the FDA throughout this process.